In a significant development for the medical imaging industry, Subtle Medical has announced that it has received clearance from the US Food and Drug Administration (FDA) for its cutting-edge CT image enhancement software.
This innovative software is designed to improve the quality and clarity of computed tomography (CT) images, enabling healthcare professionals to make more accurate diagnoses and develop effective treatment plans. The FDA clearance is a testament to the software’s safety and efficacy, and it is expected to have a profound impact on patient care.
According to the company, the software uses advanced algorithms to enhance image quality, reducing noise and artifacts that can impede diagnosis. This technology has the potential to benefit a wide range of patients, from those undergoing routine scans to those requiring complex medical interventions.
Original news story via Imaging Technology News.